Objectives: Responses to EDHF are usually characterised in the presence of nitric oxide synthase (NOS) and cyclooxygenase (COX) inhibitors. The contribution of NO to endothelium-dependent relaxation in the presence of NOS inhibitors was assessed using NO scavengers with the objective of testing (i) whether any residual NO produces endothelium-dependent relaxation in a manner similar to EDHF and (ii) to identify the source of the residual NO. Methods: Small rat hepatic and mesenteric arteries were mounted in a tension myograph for either isometric or membrane potential measurements. Results: Relaxation to ACh was unaffected by pre-treatment with G N -nitro-L-arginine methyl ester (L-NAME, 300 mM), and indomethacin (Indo, 5 mM) in the absence or presence of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 mM), nitro-L-arginine (300 mM) or L-nitro-mono-methyl-arginine (L-NMMA, 300 mM). Addition of OxyHb (20 mM) or carboxy-PTIO (300 mM) produced a significant suppression of ACh-induced relaxations (¯40%). In L-NAME1Indo treated arteries ACh-induced hyperpolarisation (D16.362.1 mV, n58) was significantly suppressed with the addition of OxyHb (D10.261.6 mV, n512). ACh-induced relaxation, in the presence of L-NAME1Indo1OxyHb, was abolished by raised 1 extracellular K , or the combination of charybdotoxin (CTX, 100 nM)1apamin (100 nM). In contrast whilst L-NAME1indo1barium1 ouabain suppressed ACh-induced relaxation, the presence of OxyHb had no additional effect. Ultraviolet light induced a relaxation in arteries treated with L-NMMA1Indo (37.065.2%, n59) which was sensitive to OxyHb (15.2610.9%, n54), and barium1ouabain (6.3962.7%, n54), but not CTX1apamin (37.862.4%, n54). Conclusions: These findings suggest that NO contributes significantly to the ''EDHF-like'' response seen in rat small arteries and that the source of this NO may be preformed vascular stores.
N O contributes to EDHF-like responses in rat small arteries: a role for NO stores a , b b a membrane potential has been attributed to modulation of 2 . Methods 1 1 K flux since raising extracellular K concentration (25-1 40 mM) [7, 8] K may contribute to EDHF responses; inhibition of their mesenteric or hepatic arteries were cleared of extraneous 21 activity using barium (Ba ) and ouabain, respectively tissue and approximately 2 mm lengths cut and mounted in attenuates EDHF responses (for review, see Edwards and a tension myograph for isometric tension measurements Weston [10] ). However, this theory is controversial, not [31] . Vessels were equilibrated for 1 h at 37 8C in PSS 1 least because K ions fail to induce hyperpolarization or bubbled with 5% CO -95% O . After this time, arteries 2 2 relaxation in some tissues that exhibit EDHF activity were normalised as previously described [35] . Vessels were [11, 12] .
then repeatedly contracted with the thromboxane A 2 To facilitate investigation of EDHF responses, it is analogue U46619 (1 mM) until two successive responses necessary to eliminate the activity of the other endowere within 10% of each other. Endothelial integrity was thelium-derived mediators; primarily prostacyclin and NO. determined using acetylcholine (ACh, 1 mM); arteries were The complete removal of these mediators is essential since deemed intact if the percentage reversal by ACh of Uboth NO and prostacyclin act, in part, by hyperpolarizing 46619-induced precontraction was greater than 50%. The smooth muscle [13, 14] and both appear to interfere with endothelium was removed by inserting a human hair into EDHF release and activity [15, 16] . Classically inhibition the lumen of the vessel, using a previously described of NO and prostacyclin is achieved using a combination of protocol [32] .
G the NO synthase (NOS) inhibitor, N -nitro-L-arginine methyl ester (L-NAME), and the cyclo-oxygenase (COX) 2 .1. Functional reactivity studies inhibitor, indomethacin (Indo). Relaxations in the presence of these two agents are attributed to an EDHF response Following equilibration, arteries were precontracted with [11, 15, 17, 18] . However, whilst Indo is reliably effective at a concentration of U46619 (1-100 nM) giving 75-90% of inhibiting prostacyclin synthesis [19, 20] , recent studies the response to 1 mM U46619. On generation of a stable suggest that NOS inhibitors alone are insufficient to baseline, a concentration-response curve to ACh (1-abolish endothelium-dependent responses accredited to NO 10,000 nM) was constructed. To dissect the mechanisms [21, 22] . Thus, despite the presence of NOS inhibitors it is involved in ACh-induced relaxation, vessels were prepossible that NO may contribute to responses that have treated with one of a range of inhibitor combinations previously been attributed to EDHF. described below or maintained as a timed control. In all In light of the above findings, we have investigated the experiments the concentration of U-46619 required to contribution of NO to the classical EDHF response in the precontract the arteries was titrated to produce a similar presence of NOS inhibitors to determine whether some of level of precontraction. the activity attributed to EDHF is due to NO activity not eliminated by NOS inhibition. In addition we have con-2 .2. Determination of optimal NO blockade ducted studies to identify the source of this residual NO. Experiments were conducted in rat mesenteric and hepatic
To determine the role that NO plays in the classical arteries; both preparations in which a significant com-EDHF response, mesenteric arteries were pre-treated with ponent of endothelium-dependent relaxation is thought to L-NAME (300 mM, 30 min) and Indo (5 mM, 30 min) in be due to EDHF activity [4, 11, 24] . In addition to NOS the presence or absence of either the sGC inhibitor, ODQ inhibitors we have used pharmacological tools affecting (1 mM, 30 min) or NO scavengers OxyHb (10 mM given the NO pathway further downstream, namely the soluble 15 min prior to precontraction and then a second 10 mM guanylate cyclase (sGC) inhibitor, 1H-[1,2,4]oxapplied just prior to application of ACh to give a total of adiazolo [4,3-a] quinoxalin-1-one (ODQ) [25] and the NO 20 mM) or carboxy-PTIO (300 mM, 30 min). To ascertain scavengers oxy-haemoglobin (OxyHb) [26] and 2-(4-carwhether maximal NOS inhibition was achieved using Lboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-NAME, two other NOS inhibitors were also tested: nitro-Loxide (carboxy-PTIO) [27] [28] [29] . Some of these results have arginine (L-NOLA, 300 mM) or L-nitro-mono-methyl-arbeen presented in a preliminary form to the British ginine (L-NMMA, 300 mM) in combination with L-NAME Pharmacological Society [30] .
(30 mM)1Indo (5 mM). These combinations were chosen by guest on May 2, 2016
Downloaded from since previous studies suggest that these particular combiin this study since it contains a nitro group, which releases nations produce greater NOS inhibition than any of the NO when exposed to ultraviolet light [35] . individual NOS inhibitors at the maximally effective concentration (300 mM) [ The experiments with Ba 1ouabain were repeated in The potency of ACh is expressed as the negative logarithm rat hepatic arteries; a preparation in which a significant of the EC (pEC ), which was calculated using either 50 50 component of the EDHF response has previously been Prism Graphpad or SPSS software. All data is shown as shown to be sensitive to these agents [21] . To determine mean6S.E.M. Tests of significance between curves were 21 whether Ba 1ouabain had a direct effect on NO meconducted using either two-way analysis of variance diated relaxation the response to the NO donor sodium (ANOVA) for multiple comparisons or a general linear nitroprusside (SNP, 1-10,000 nM) was determined in the model for three or more curves. Students t-test were used absence or presence of these inhibitors.
to compare the differences between two data groups, where P,0.05 was considered significant. The n values quoted similarly indicate the number of experiments and animals 2 . 4 
. Effect of OxyHb and inhibitors of potassium flux on used. photorelaxation
To determine whether preformed NO stores were pres-2 .7. Drugs and material ent in rat mesenteric arteries, vessels were subjected to ultraviolet illumination, a procedure thought to result in the All drugs were obtained from Sigma (Poole, UK), release of NO from NO-thiol stores [33, 34] . In brief, except U46619 (Biomol), charybdotoxin and apamin (Tocarteries were pre-contracted with U46619 (10-100 nM), ris Laboratories), carboxy-PTIO (Calbiochem Novabiochand then exposed to ultraviolet light (15 exposures at em) and ODQ which was a kind gift from Professor wavelength of 366 nm, over a 20 s period). The mechaGarthwaite, The Wolfson Institute for Biomedical Renisms by which NO, from this source, caused vasorelaxasearch, London. Human haemoglobin was reduced using tion were investigated using selective inhibitors and blocksodium dithionate [36] . ers as described above. Arteries were treated with LStock solutions of U-46619 were made in 100% ethanol NMMA (300 mM)1Indo (5 mM), in the presence and and kept at 220 8C. On the day of experimentation the first absence of one of the following combinations: OxyHb, dilution of U-46619 was made in ethanol-saline (50:50), 21 CTX1apamin, or Ba 1ouabain (concentrations as and successive dilutions in 100% saline. Stock solutions of above). Finally, to determine the location of these stores, ODQ and ouabain in 100% dimethylsulphoxide (DMSO), experiments were conducted in endothelium-denuded ves-CTX and apamin in water were stored at 220 8C until day sels treated with L-NMMA1Indo. L-NAME was not used of use. Indo was made freshly each day in 1% sodium mN (n537), i.e., 4.260.3% of maximal contraction to 1 mM U46619, that returned to baseline levels after a few minutes, and CTX1apamin which caused a sustained contraction of 8.162.4 mN; n511 (36.7612.2%).
.1. Effect of oxy-haemoglobin, ODQ and carboxy-PTIO on EDHF responses
ACh caused concentration-dependent relaxation of rat mesenteric arteries that was unaffected by pre-treatment with L-NAME1Indo (Fig. 1, Table 1 ). Addition of ODQ to the cocktail of inhibitors had no additional effect on ACh-induced relaxation response curves (Fig. 1, Table 1 ). In contrast, addition of OxyHb significantly depressed the maximal relaxation to ACh but had no significant effect on potency (Fig. 1, Table 1 ). Similarly addition of carboxy-PTIO significantly (P,0.001) suppressed ACh induced relaxation. The presence of L-NAME in addition to OxyHb and Indo was necessary and sufficient for optimal NO blockade; OxyHb and Indo alone reduced maximum relaxation to only 78.5612.4% of control (n57), and addition of other NOS inhibitors; L-NOLA or L-NMMA to In rat mesenteric arteries, elevation of extracellular K to 30 mM raised basal tension by 30.764.4% (% of bicarbonate in saline. All other drugs were dissolved in contraction to 1 mM U46619); 7.5261.3 mN (n511). saline. All dilutions were made in saline on day of use.
U-46619 (1-10 nM) was then titrated to produce a comparable level of precontraction to that used in the previous experiments, i.e., 75-90% of maximum contrac-3 . Results tion to 1 mM U-46619. In the presence of L-NAME1 1 Indo1OxyHb, elevation of K abolished the remnant The normalised diameter of the vessels studied was ACh-induced relaxation and exposed concentration-depen-(RMA5285.367.9 mm; RHA5221.969.2 mm). ACh dent contraction to ACh (pEC 57.060.3, n511; Fig.   50 caused concentration-dependent relaxation that was 2A). Similarly, CTX1apamin treatment abolished the abolished in endothelium-denuded vessels (maximum reremnant relaxation to ACh, and unmasked a contractile laxation 9.065.8%; n56; P.0.05). Basal tension was response (pEC 56.860.7, n511; Fig. 2B ). In the pres- 50 unaffected by drug treatments with the exceptions of ence of L-NAME1Indo (pEC 57.360.1, max.5 50 21 OxyHb, which caused a transient contraction of 1.360.5 89.761.2%, n55), addition of either Ba 1ouabain drug cocktails as the mesenteric arteries. Pre-treatment of vessels with L-NAME1Indo1OxyHb suppressed AChinduced relaxation (Fig. 4A, Table 2 ). Treatment of 21 hepatic arteries with L-NAME1Indo1Ba 1ouabain also significantly suppressed ACh-induced relaxation (Fig. 4A , Table 2 ). However, addition of OxyHb to this cocktail, had no additional effect (Fig. 4A, Table 2 ). SNP produced concentration dependent relaxation of rat hepatic arteries (pEC 56.960.14, max.582.664.31%, n54), which was 50 significantly (P,0.001) attenuated in the presence of (Fig. 4B) .
absence, and in the presence of L-NAME (300 mM), indomethacin (Indo, 5 mM) and oxy-haemoglobin (OxyHb, 20 mM) and (A) combined with raised extracellualar potassium (KCl, 30 mM) or (B) combined with
.3. Effect of OxyHb and potassium channel inhibitors
charybdotoxin (CTX, 100 nM) and apamin (100 nM). Values shown are on photorelaxation mean6S.E.M. Statistical analysis depicted as *P,0.01 or **P,0.001 compared to the untreated vessels using two-way ANOVA, and [P,0.01 as compared to L-NAME1Indo1OxyHb using general linear regression Ultraviolet light exposure caused a relaxation in mesen- apamin had no effect on ultraviolet light-induced relaxa- 50 The rat hepatic artery showed similar sensitivity to the tion (37.862.4%, n54) (Fig. 5) .
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Downloaded from vessels with L-NAME1Indo had no significant effect on resting membrane potential (256.762.7 mV, n58). Under these conditions ACh (10 mM) caused a 16.362.1 mV (n58) hyperpolarization. Addition of OxyHb, to these L-NAME1Indo treated arteries, had no effect on membrane potential per se (253.563.0 mV, n512) but significantly reduced (P, 0.05) the hyperpolarization response to ACh (10.261.6 mV, n512) (see Fig. 6A and B for typical responses).
. Discussion
It is generally accepted that EDHF is responsible for the hyperpolarizing component of endothelium-dependent relaxation in the presence of NOS and COX inhibition. However, the current study suggests that, despite blockade of NOS and COX activity, NO still accounts for a major component of ACh-induced relaxation in rat mesenteric and hepatic small arteries attributed to EDHF. It is only upon further removal of NO, achieved using NO scavengers, that an environment in which responses to ''classical'' EDHF can then be clearly dissected. In addition this NOS inhibitor-resistant NO may be derived from endothelial NO stores and causes relaxation via the activation of potassium channels.
The arteries used for this study were chosen since a significant component of ACh-induced relaxation (95%) in both rat mesenteric [2] and hepatic arteries [24] is believed to be mediated by EDHF. Consistent with these observations, inhibition of NOS and COX, with concentrations of L-NAME and Indo thought to maximally inhibit enzyme activity, had little effect on ACh responses in both types of artery as demonstrated in this and previous studies [37] [38] [39] [40] [41] . Furthermore application of more than one NOS inhibitor had no greater effect than L-NAME alone indicating that the concentration of NOS inhibitor used in these studies was maximally effective. Classically the remnant relaxation to endothelium-dependent vasodilators in the presence of NOS and COX inhibitors has been attributed application of 1.5 mM with a 10 min pre-treatment was used. Although low-dose OxyHb was shown to block the Data are shown as mean6S.E.M. L-NAME5L-Nitro-arginine methyl ester, Indo5indomethacin, OxyHb5oxy-haemoglobin, Ba 5barium. Statistical analysis depicted as *P,0.05, **P,0.01, ***P,0.001 compared to the control vessels using one-way ANOVA followed by Bonferroni post-hoc tests.
carboxy-PTIO, also attenuated ACh-induced relaxation.
contraction). The difference between these studies and the Results from this study suggest that L-NAME does not current may be explained by the fact that only in the optimally inhibit NO-dependent responses in these prepaabsence of all endothelial derived relaxing factors, does rations; indeed studies measuring ACh-induced NO reACh produce a contractile response. This is only observed lease, using an NO microsensor, from arteries including rat in the presence of an NO scavenger and suggests that mesenteric artery [15, 23] demonstrate residual NO mearemnant NO may account for the absence of ACh-induced surement despite NOS inhibition.
contraction in other vessels. From the present study it is clear that NO mediates a
The L-NAME-insensitive but OxyHb-sensitive NO commajor component of ACh-induced relaxation in mesenteric ponent of ACh-induced relaxation, in mesenteric arteries, and hepatic arteries, and a significant concentration-dependid not involve activation of sGC, since the selective dent relaxation to ACh still remains in the presence of inhibitor, ODQ, had no effect on ACh responses in the optimal NO and prostacyclin blockade. This response is presence of L-NAME1Indo. This dose of ODQ blocks most likely due to EDHF activity since it is abolished by ACh-induced relaxation of rabbit aorta, a response known 1 raising extracellular K and by CTX1apamin treatment, to be entirely NO mediated, inhibits endothelium-depenas in other arteries [43] [44] [45] and confirms that these dent relaxation of rat aorta, and produces maximal inhibi-1 modulators of K flux antagonise EDHF-mediated relaxation of GC activity [25, 47] . Indeed there is precedent for tions. Additionally following complete NO, prostacyclin sGC-independent mechanisms of NO mediated relaxation, and EDHF blockade ACh causes concentration-dependent including direct hyperpolarization of vascular smooth contraction. This is in contrast to other studies [4, 46] , muscle by authentic NO and NO donors [21, [48] [49] [50] . It is where blockade of EDHF responses resulted merely in an probable that this is the mechanism for NO-mediated 21 absence of any response to ACh (i.e., no relaxation and no relaxation in the current study, since Ba 1ouabain alter the exact mechanisms involved in ACh-induced relaxation [51] . However the data do show that OxyHb, which profoundly suppresses ACh-induced relaxation, also significantly suppresses ACh-induced hyperpolarization. Consistent with this, relaxations to the NO donor SNP are 21 partially inhibited by Ba 1ouabain in rat hepatic arteries suggesting NO-induced activation of K and the Na / K IR ATPase: activity which is shared by a variety of different NO donors in several different artery types [52, 53] . Our data support the hypothesis that endogenously generated NO similarly to NO donors also causes hyperpolarisation of vascular smooth muscle. Interestingly, unlike CTX1 1 21 apamin or raised K , treatment with Ba and ouabain, in the presence of OxyHb, whilst having a slightly greater effect than OxyHb alone did not convert ACh relaxation into contraction. These results suggest that a major component of EDHF responses previously shown to be sensitive to blockade of K and the Na / K ATPase, reflects IR only a minimal EDHF blocking capacity and, in the large part is due to block of NO-mediated responses. The source of this NOS inhibitor-insensitive, but OxyHb-sensitive component of ACh-induced relaxation may be NO release from a pre-formed thiol store. Exposure to ultraviolet light releases NO from preformed stores in certain blood vessels [54] . Accordingly in the present study ultraviolet light caused relaxation of endothelium intact mesenteric arteries treated with L-NMMA1Indo. These responses where significantly inhibited by either 21 OxyHb or Ba 1ouabain, but insensitive to CTX1 apamin. Consistent with this, other studies also show NO release from such stores mediates OxyHb sensitive [32] vasorelaxation by causing hyperpolarisation of vascular smooth muscle [55] [56] [57] [58] . The location of this store is likely to be within the endothelial cell, since removal of the endothelium abolished ultraviolet light-induced relaxation. In addition that NO from these stores cause relaxation by analysis using unpaired t-test shown as *P,0.05. directly hyperpolarizing vascular smooth muscle. An alternative explanation for our findings is that NO-store derived application blocked ACh-induced relaxation. Moreover our NO might operate by stimulating the release of EDHF. electrophysiological studies show that in the presence of This is unlikely since several lines of evidence point to an L-NAME1Indo ACh-induced hyperpolarization was siginhibitory effect of NO on EDHF release [16] . However nificantly reduced (¯40%) by OxyHb to a level that further experiments investigating the hyperpolarizing naapproximately matches the proportion of ACh relaxation ture of NO in endothelium-denuded and intact preparations sensitive to OxyHb, i.e., 50%. This suggests that NO might address this issue. mediates a component of ACh-induced hyperpolarization
The clinical relevance of NO stores is unclear but it is of vascular smooth muscle. These experiments were possible that in diseases where NO production is impaired, conducted in non-depolarised tissues. It is possible that e.g., endotoxaemia or hypertension, NO-stores may serve different mechanisms may be involved in ACh-induced as a compensatory vascular NO supply. Indeed, Kubaszewhyperpolarization in depolarised and non-depolarised tisski et al. [59] , demonstrated that photorelaxation in sues, indeed even the mechanism of contraction appears to hypertensive rats was enhanced compared to controls. It is released from these stores is still unclear. A cknowledgements
